Hochdorf generated a net sales revenue of CHF 561.0 m in 2018 (−6.6 % compared to previous year (PY)). Earnings before interest and taxes (Ebit) amounted to CHF 18.6 m (−56.2 % PY) with a net profit of CHF 8.7 m (PY CHF 40.8 m). At 3.3 %, Ebit as a percentage of production revenue is slightly below the predicted range of 3.5 to 4.0 %.

Although significantly below the record figures of the previous year, the sales and earnings figures are within those forecast by the company in December 2018. The main reasons for the disappointing results are the significantly lower performance of Pharmalys Laboratories SA, the lack of sales in China, delays in the new spray tower line and a worsening of the problems in the Dairy Ingredients division, as well as the one-off effect from the sale of Hochdorf Baltic Milk UAB.